Enaside 20/12,5 20 mg and 12,5 mg Tablets
PDF Leaflet Revision Date: 10 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension where fixed combination therapy is preferred.
Dosage (summary)
1 tablet once daily, may increase to 2 tablets once daily if needed.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; switch to alternative therapy if pregnancy occurs.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- Fluoroquinolones
Contraindications
- Hypersensitivity to components
- Severe renal impairment
- Anuria
- Angioedema history
- Pregnancy
- Lactation
Common side effects
- Headache
- Cough
- Hypotension
- Dizziness
Counselling Points
- Monitor blood pressure regularly
- Report signs of angioedema
- Avoid potassium supplements without consulting
Serious warnings
- Risk of hypotension
- Electrolyte imbalance
- Angioedema risk
Important Disclaimer
The Enaside 20/12,5 20 mg and 12,5 mg Tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
